Skip to main content
Clinical Trials/NCT03644329
NCT03644329
Unknown
Not Applicable

Effect of Resistance Training Variable Manipulation (Intensity and Volume) on Body Composition, Fatigability and Functional Capacity in Postmenopausal Breast Cancer Survivors.

Universidade Federal do Triangulo Mineiro1 site in 1 country80 target enrollmentMay 13, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer Survivors
Sponsor
Universidade Federal do Triangulo Mineiro
Enrollment
80
Locations
1
Primary Endpoint
Evaluation the Fatigability
Last Updated
7 years ago

Overview

Brief Summary

This study intends to evaluate the impact of resistance training variable manipulation (intensity and volume) on body composition, fatigability and functional capacity in postmenopausal breast cancer survivors.

Detailed Description

The treatment for breast cancer (chemotherapy, radiotherapy and hormone therapy) provokes collateral effects,such as muscle mass and strength losses, increase of fat mass, fatigue and disability and reduced quality of life in postmenopausal breast cancer survivors. The resistance training is assumed as a non-pharmacologic interventions in postmenopausal breast cancer survivors. However, it is unclear whether the manipulation of training variables (intensity and volume) maximize the effects of resistance training on body composition, fatigability and functional capacity in postmenopausal breast cancer survivors.

Registry
clinicaltrials.gov
Start Date
May 13, 2018
End Date
December 20, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Fábio Lera Orsatti

Principal Investigator

Universidade Federal do Triangulo Mineiro

Eligibility Criteria

Inclusion Criteria

  • Postmenopausal breast cancer survivors;
  • No supervised or unsupervised exercise at least for six months prior to the study.

Exclusion Criteria

  • Alcoholics;
  • No controlled blood pressure and glucose;
  • Presence of myopathies, arthropathies, and neuropathies;
  • Presence of muscle, thromboembolic and gastrointestinal disorders, infection diseases.

Outcomes

Primary Outcomes

Evaluation the Fatigability

Time Frame: pre and post intervention (i.e. 12 weeks)

The fatigability will be evaluate by 60 maximum voluntary isometric contractions (3 s contraction, 2 s rest) in knee extensors at 70 degree

Secondary Outcomes

  • Four- meter walk test(pre and post intervention (i.e. 12 weeks))
  • Six Minutes-walk test (6MWT)(pre and post intervention (i.e. 12 weeks))
  • Timed Up and Go test(pre and post intervention (i.e. 12 weeks))
  • Fat mass(pre intervention and post intervention (i.e. 12 weeks))
  • 10-meter walk test(pre and post intervention (i.e. 12 weeks))
  • 400-meter walk test(pre and post intervention (i.e. 12 weeks))
  • 900-meter walk test(pre and post intervention (i.e. 12 weeks))
  • Muscle mass(pre and post intervention (i.e. 12 weeks))
  • Muscle strength(pre and post intervention (i.e. 12 weeks))
  • Five-times-sit-to-stand test(pre and post intervention (i.e. 12 weeks))

Study Sites (1)

Loading locations...

Similar Trials